SAN DIEGO--(BUSINESS WIRE)--Nov. 8, 2017--
Illumina, Inc. (NASDAQ: ILMN) announced today that Gary S. Guthart will
join the company’s Board of Directors on December 1, 2017. Dr. Guthart
is President and Chief Executive Officer of Intuitive Surgical, a global
leader in the field of robotic-assisted minimally invasive surgery.
This press release features multimedia. View the full release here:
Gary Guthart (Photo: Business Wire)
Dr. Guthart joined Intuitive Surgical in April 1996 and has served as
the Chief Executive Officer since January 2010. In July 2007, he was
promoted to President, having assumed the role of Chief Operating
Officer in February 2006. Prior to joining Intuitive Surgical, he was
part of the core team developing the foundational technology for
computer-enhanced surgery at SRI International (formerly Stanford
Research Institute). Dr. Guthart served as a member of the Board of
Directors of Affymetrix, Inc. from May 2009 until its acquisition by
Thermo Fisher Scientific Inc. in March 2016.
“Gary is a talented leader who adds a tremendous breadth of industry
knowledge and experience to our exceptional board of directors,” said
Francis deSouza, Illumina President and Chief Executive Officer. “He
will bring leadership, strategy and policy expertise in the healthcare
sector as Illumina continues to drive adoption of genomics in clinical
Dr. Guthart received a B.S. in Engineering from the University of
California, Berkeley and an M.S. and a Ph.D. in Engineering Science from
the California Institute of Technology.
Illumina is improving human health by unlocking the power of the genome.
Our focus on innovation has established us as the global leader in DNA
sequencing and array-based technologies, serving customers in the
research, clinical and applied markets. Our products are used for
applications in the life sciences, oncology, reproductive health,
agriculture, and other emerging segments. To learn more, visit www.illumina.com and
View source version on businesswire.com: http://www.businesswire.com/news/home/20171108005548/en/
Source: Illumina, Inc.
Jacquie Ross, CFA